z-logo
open-access-imgOpen Access
Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans?
Author(s) -
Meena Asmar,
M. Bache,
Filip K. Knop,
Sten Madsbad,
Jens J. Holst
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-2133
Subject(s) - amylin , gastric emptying , appetite , medicine , endocrinology , postprandial , glucagon , incretin , glucagon like peptide 1 , peptide yy , crossover study , insulin , meal , diabetes mellitus , type 2 diabetes , stomach , neuropeptide , islet , placebo , receptor , neuropeptide y receptor , alternative medicine , pathology
Amylin, cosecreted with insulin, has like glucagon-like peptide-1 (GLP-1) been reported to inhibit glucagon secretion, delay gastric emptying, and reduce appetite and food intake. We investigated whether the effects of GLP-1 on gastric emptying, appetite, and food intake are mediated directly or indirectly via release of amylin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom